Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer

11:42 EDT 1 Jun 2018 | NEJM

More From BioPortfolio on "Serum chromogranin-A-based prognosis in metastatic castration-resistant prostate cancer"